Brought to you by 
SeraCare acquires Genomics Collaborative for cash and stock
09 Jul 2004
Executive Summary
To strengthen its proteomics/genomics capabilities, expand its biomarker validation and drug discovery efforts, and increase its data and clinical specimen offerings to the drug, diagnostic, and research communities, SeraCare Life Sciences has acquired all the assets of privately held Genomics Collaborative Inc. (research tools and services for therapeutic and diagnostic applications).
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SeraCare acquires Genomics Collaborative for cash and stock
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice